A comparative North American experience of robotic thyroidectomy in a thyroid cancer population

Salem I. Noureldine, Nicole R. Jackson, Ralph P Tufano, Emad Kandil

Research output: Contribution to journalArticle

Abstract

Purpose: This study seeks to explore the efficacy of robotic thyroidectomy in treating a North American population with differentiated thyroid cancer (DTC) as compared with the conventional cervical approach. Methods: A retrospective analysis of our prospectively collected thyroid surgery database was performed. We included all consecutive patients that underwent thyroidectomy for the treatment of well-differentiated thyroid cancer, performed by a single surgeon. Results: Twenty-four robotic transaxillary and 35 conventional thyroidectomy procedures were performed. Average size of the tumor was 1.1 ± 0.2 cm in the robotic group and 1.7 ± 0.3 cm in the cervical group (p = 0.16). Average total operative time for the robotic group was 133 ± 65.4 and 119.7 ± 22.5 min in the cervical group (p = 0.34). No robotic cases required conversion. One patient required reoperation for recurrent disease at 24 months follow-up. Both groups had similar blood loss (p = 0.37) and all margins were negative for malignancy on permanent pathology. All patients were discharged home within 24 h. Postoperative stimulated thyroglobulin levels were similar for the two groups (p = 0.82). Conclusions: Our experience with robotic transaxillary thyroidectomy confirms this technique is feasible. It is possible to achieve a safe and effective oncologic result in a select group of North American patients with DTC.

Original languageEnglish (US)
Pages (from-to)1069-1074
Number of pages6
JournalLangenbeck's Archives of Surgery
Volume398
Issue number8
DOIs
StatePublished - Dec 2013

Fingerprint

Thyroidectomy
Robotics
Thyroid Neoplasms
Population
Thyroglobulin
Operative Time
Reoperation
Neoplasms
Thyroid Gland
Databases
Pathology

Keywords

  • Comparative study
  • DTC
  • Papillary thyroid cancer
  • Robotic thyroidectomy
  • Thyroid neoplasm
  • Thyroid surgery
  • Transaxillary
  • Well-differentiated thyroid cancer

ASJC Scopus subject areas

  • Surgery

Cite this

A comparative North American experience of robotic thyroidectomy in a thyroid cancer population. / Noureldine, Salem I.; Jackson, Nicole R.; Tufano, Ralph P; Kandil, Emad.

In: Langenbeck's Archives of Surgery, Vol. 398, No. 8, 12.2013, p. 1069-1074.

Research output: Contribution to journalArticle

Noureldine, Salem I. ; Jackson, Nicole R. ; Tufano, Ralph P ; Kandil, Emad. / A comparative North American experience of robotic thyroidectomy in a thyroid cancer population. In: Langenbeck's Archives of Surgery. 2013 ; Vol. 398, No. 8. pp. 1069-1074.
@article{93589f62c5d54dcaad42a0f49dac841a,
title = "A comparative North American experience of robotic thyroidectomy in a thyroid cancer population",
abstract = "Purpose: This study seeks to explore the efficacy of robotic thyroidectomy in treating a North American population with differentiated thyroid cancer (DTC) as compared with the conventional cervical approach. Methods: A retrospective analysis of our prospectively collected thyroid surgery database was performed. We included all consecutive patients that underwent thyroidectomy for the treatment of well-differentiated thyroid cancer, performed by a single surgeon. Results: Twenty-four robotic transaxillary and 35 conventional thyroidectomy procedures were performed. Average size of the tumor was 1.1 ± 0.2 cm in the robotic group and 1.7 ± 0.3 cm in the cervical group (p = 0.16). Average total operative time for the robotic group was 133 ± 65.4 and 119.7 ± 22.5 min in the cervical group (p = 0.34). No robotic cases required conversion. One patient required reoperation for recurrent disease at 24 months follow-up. Both groups had similar blood loss (p = 0.37) and all margins were negative for malignancy on permanent pathology. All patients were discharged home within 24 h. Postoperative stimulated thyroglobulin levels were similar for the two groups (p = 0.82). Conclusions: Our experience with robotic transaxillary thyroidectomy confirms this technique is feasible. It is possible to achieve a safe and effective oncologic result in a select group of North American patients with DTC.",
keywords = "Comparative study, DTC, Papillary thyroid cancer, Robotic thyroidectomy, Thyroid neoplasm, Thyroid surgery, Transaxillary, Well-differentiated thyroid cancer",
author = "Noureldine, {Salem I.} and Jackson, {Nicole R.} and Tufano, {Ralph P} and Emad Kandil",
year = "2013",
month = "12",
doi = "10.1007/s00423-013-1123-0",
language = "English (US)",
volume = "398",
pages = "1069--1074",
journal = "Langenbeck's Archives of Surgery",
issn = "1435-2443",
publisher = "Springer Verlag",
number = "8",

}

TY - JOUR

T1 - A comparative North American experience of robotic thyroidectomy in a thyroid cancer population

AU - Noureldine, Salem I.

AU - Jackson, Nicole R.

AU - Tufano, Ralph P

AU - Kandil, Emad

PY - 2013/12

Y1 - 2013/12

N2 - Purpose: This study seeks to explore the efficacy of robotic thyroidectomy in treating a North American population with differentiated thyroid cancer (DTC) as compared with the conventional cervical approach. Methods: A retrospective analysis of our prospectively collected thyroid surgery database was performed. We included all consecutive patients that underwent thyroidectomy for the treatment of well-differentiated thyroid cancer, performed by a single surgeon. Results: Twenty-four robotic transaxillary and 35 conventional thyroidectomy procedures were performed. Average size of the tumor was 1.1 ± 0.2 cm in the robotic group and 1.7 ± 0.3 cm in the cervical group (p = 0.16). Average total operative time for the robotic group was 133 ± 65.4 and 119.7 ± 22.5 min in the cervical group (p = 0.34). No robotic cases required conversion. One patient required reoperation for recurrent disease at 24 months follow-up. Both groups had similar blood loss (p = 0.37) and all margins were negative for malignancy on permanent pathology. All patients were discharged home within 24 h. Postoperative stimulated thyroglobulin levels were similar for the two groups (p = 0.82). Conclusions: Our experience with robotic transaxillary thyroidectomy confirms this technique is feasible. It is possible to achieve a safe and effective oncologic result in a select group of North American patients with DTC.

AB - Purpose: This study seeks to explore the efficacy of robotic thyroidectomy in treating a North American population with differentiated thyroid cancer (DTC) as compared with the conventional cervical approach. Methods: A retrospective analysis of our prospectively collected thyroid surgery database was performed. We included all consecutive patients that underwent thyroidectomy for the treatment of well-differentiated thyroid cancer, performed by a single surgeon. Results: Twenty-four robotic transaxillary and 35 conventional thyroidectomy procedures were performed. Average size of the tumor was 1.1 ± 0.2 cm in the robotic group and 1.7 ± 0.3 cm in the cervical group (p = 0.16). Average total operative time for the robotic group was 133 ± 65.4 and 119.7 ± 22.5 min in the cervical group (p = 0.34). No robotic cases required conversion. One patient required reoperation for recurrent disease at 24 months follow-up. Both groups had similar blood loss (p = 0.37) and all margins were negative for malignancy on permanent pathology. All patients were discharged home within 24 h. Postoperative stimulated thyroglobulin levels were similar for the two groups (p = 0.82). Conclusions: Our experience with robotic transaxillary thyroidectomy confirms this technique is feasible. It is possible to achieve a safe and effective oncologic result in a select group of North American patients with DTC.

KW - Comparative study

KW - DTC

KW - Papillary thyroid cancer

KW - Robotic thyroidectomy

KW - Thyroid neoplasm

KW - Thyroid surgery

KW - Transaxillary

KW - Well-differentiated thyroid cancer

UR - http://www.scopus.com/inward/record.url?scp=84890513372&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84890513372&partnerID=8YFLogxK

U2 - 10.1007/s00423-013-1123-0

DO - 10.1007/s00423-013-1123-0

M3 - Article

C2 - 24057319

AN - SCOPUS:84890513372

VL - 398

SP - 1069

EP - 1074

JO - Langenbeck's Archives of Surgery

JF - Langenbeck's Archives of Surgery

SN - 1435-2443

IS - 8

ER -